Tweetable abstract Obstructive sleep apnoea is a risk factor for cardiovascular morbidity and
mortality. There is a need for innovative research strategies evaluating the positive …

Purpose Continuous positive airway pressure (CPAP) therapy may decrease the risk of
mortality and cardiovascular events in patients with obstructive sleep apnea. However, these …

1. Peker Y, Glantz H, Eulenburg C, Wegscheider K, Herlitz J, Thunstrom E. Effect of positive
airway pressure on cardiovascular outcomes in coronary artery disease patients with …

The prevalence of obstructive sleep apnea (OSA) is 3% to 7% in the general population [1].
OSA has been found to be associated with cardiovascular disease, leading to high rates of …

Rationale: Randomized controlled trials do not support a role for continuous positive airway
pressure (CPAP) in preventing major cardiovascular events or mortality in patients with …

Background: Continuous positive airway pressure (CPAP) has been utilized to reduce blood
pressure in obstructive sleep apnea (OSA) patients, but few studies are available in terms of …

Cardiovascular disease remains the leading cause of morbidity and mortality in developed
countries. Obstructive sleep apnea is a highly prevalent condition characterized by repetitive …

Obstructive sleep apnea (OSA) commonly occurs in patients with increased cardiovascular
(CV) risk, and continuous positive airway pressure (CPAP) is the preferred therapy for these …

Prospective studies show an association between obstructive sleep apnea and
cardiovascular disease. Continuous positive airway pressure (CPAP) is the treatment of …

Background: Obstructive sleep apnoea (OSA) is highly prevalent and significantly
associated with major adverse cardiovascular events (MACEs). Continuous positive airway …